{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:45:44Z","timestamp":1793313944479,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government"},{"name":"the JSPS Core-to-Core Program, A. Advanced Research Networks"},{"name":"scientific research from the Japanese Ministry of Health, Labor and Welfare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To investigate the role of miRNA in the pathogenesis underlying ocular surface complications in patients with Stevens\u2013Johnson syndrome (SJS)\/toxic epidermal necrolysis (TEN) in the chronic stage. Using oligonucleotide microarrays, we performed comprehensive miRNA analysis of the conjunctival epithelium of SJS\/TEN patients with severe ocular complications (SOC) in the chronic stage (n\u2009=\u20093). Conjunctival epithelium of patients with conjunctival chalasis (n\u2009=\u20093) served as the control. We confirmed the down- and up-regulation of miRNA of interest by quantitative real-time polymerase chain reaction (RT-PCR) assays using the conjunctival epithelium from 6 SJS\/TEN with SOC patients and 7 controls. We focused on miRNA-455-3p, which is significantly upregulated in the conjunctival epithelium of the SJS\/TEN patients, and investigated its function by inhibiting miR-455-3p in primary human conjunctival epithelial cells (PHCjEs). Comprehensive miRNA expression analysis showed that the expression of 5 kinds of miRNA was up-regulated more than fivefold, and that the expression of another 5 kinds of miRNA was down-regulated by less than one-fifth. There was a significant difference between the SJS\/TEN patients and the controls [analysis of variance (ANOVA) p\u2009&lt;\u20090.05]. Quantitative miRNA PCR assay showed that hsa-miR-31* and hsa-miR-455-3p were significantly up-regulated in the conjunctival epithelium of the SJS\/TEN patients. Comprehensive gene expression analysis of PHCjEs transfected with the hsa-miR-455-3p inhibitor and quantitative RT PCR assay showed that ANKRD1, CXCL8, CXCL2, GEM, PTGS2, RNASE8, IL6, and CXCL1 were down-regulated by the hsa-miR-455-3p inhibitor. Quantitative RT-PCR, focused on the genes that tended to be up-regulated in SJS\/TEN with SOC, revealed that the expression of IL1A, KPRP, IL36G, PPP1R3C, and ADM was significantly down-regulated in PHCjEs transfected with the hsa-miR-455-3p inhibitor. Our results suggest that miRNA-455-3p could regulate many genes including innate immune related genes in human conjunctival epithelium, and that its up-regulation contributes to the pathogenesis on the ocular surface in SJS\/TEN patients with the SOC in the chronic stage. Our findings may lead to the development of new treatments using the miRNA-455-3p inhibitor.<\/jats:p>","DOI":"10.1038\/s41598-020-74211-9","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T10:04:52Z","timestamp":1602669892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens\u2013Johnson syndrome in the chronic stage"],"prefix":"10.1038","volume":"10","author":[{"given":"Mayumi","family":"Ueta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsura","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"74211_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","volume":"160","author":"C Sotozono","year":"2015","unstructured":"Sotozono, C. et al. Predictive factors associated with acute ocular involvement in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Am. J. Ophthalmol. 160, 228\u201337.e2 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"74211_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2010.08.007","volume":"126","author":"M Ueta","year":"2010","unstructured":"Ueta, M. et al. Association between prostaglandin E receptor 3 polymorphisms and Stevens\u2013Johnson syndrome identified by means of a genome-wide association study. J. Allergy Clin. Immunol. 126, 1218-1225.e10 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"74211_CR3","doi-asserted-by":"publisher","first-page":"e43650","DOI":"10.1371\/journal.pone.0043650","volume":"7","author":"M Ueta","year":"2012","unstructured":"Ueta, M. et al. HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens\u2013Johnson syndrome with severe ocular surface complications. PLoS ONE 7, e43650 (2012).","journal-title":"PLoS ONE"},{"key":"74211_CR4","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1038\/srep04862","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M. et al. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens\u2013Johnson syndrome with severe mucosal involvement. Sci. Rep. 4, 4862 (2014).","journal-title":"Sci. Rep."},{"key":"74211_CR5","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jaci.2014.12.1916","volume":"135","author":"M Ueta","year":"2015","unstructured":"Ueta, M. et al. IKZF1, a new susceptibility gene for cold medicine-related Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with severe mucosal involvement. J. Allergy Clin. Immunol. 135, 1538-1545.e17 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"74211_CR6","doi-asserted-by":"publisher","first-page":"15023","DOI":"10.1038\/hgv.2015.23","volume":"2","author":"M Ueta","year":"2015","unstructured":"Ueta, M. et al. HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens\u2013Johnson syndrome with severe ocular complications. Hum. Genome Var. 2, 15023 (2015).","journal-title":"Hum. Genome Var."},{"key":"74211_CR7","doi-asserted-by":"publisher","first-page":"e000073","DOI":"10.1136\/bmjophth-2017-000073","volume":"1","author":"M Ueta","year":"2017","unstructured":"Ueta, M., Nishigaki, H., Sotozono, C. & Kinoshita, S. Downregulation of interferon-gamma-induced protein 10 in the tears of patients with Stevens\u2013Johnson syndrome with severe ocular complications in the chronic stage. BMJ Open Ophthalmol. 1, e000073 (2017).","journal-title":"BMJ Open Ophthalmol."},{"key":"74211_CR8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","volume":"114","author":"C Sotozono","year":"2007","unstructured":"Sotozono, C. et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens\u2013Johnson syndrome. Ophthalmology 114, 1294\u20131302 (2007).","journal-title":"Ophthalmology"},{"key":"74211_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.preteyeres.2012.05.003","volume":"31","author":"M Ueta","year":"2012","unstructured":"Ueta, M. & Kinoshita, S. Ocular surface inflammation is regulated by innate immunity. Prog. Retin. Eye Res. 31, 551\u2013575 (2012).","journal-title":"Prog. Retin. Eye Res."},{"key":"74211_CR10","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/bjo.2006.113449","volume":"91","author":"M Ueta","year":"2007","unstructured":"Ueta, M. et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens\u2013Johnson syndrome. Br. J. Ophthalmol. 91, 962\u2013965 (2007).","journal-title":"Br. J. Ophthalmol."},{"key":"74211_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ajo.2006.09.029","volume":"143","author":"M Ueta","year":"2007","unstructured":"Ueta, M., Sotozono, C., Tokunaga, K., Yabe, T. & Kinoshita, S. Strong association between HLA-A*0206 and Stevens\u2013Johnson syndrome in the Japanese. Am. J. Ophthalmol. 143, 367\u2013368 (2007).","journal-title":"Am. J. Ophthalmol."},{"key":"74211_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/1744666X.2020.1729128","volume":"16","author":"M Ueta","year":"2020","unstructured":"Ueta, M. Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications. Expert Rev. Clin. Immunol. 16, 285\u2013291 (2020).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"74211_CR13","first-page":"161","volume":"2","author":"AM Ardekani","year":"2010","unstructured":"Ardekani, A. M. & Naeini, M. M. The role of MicroRNAs in human diseases. Avicenna J. Med. Biotechnol. 2, 161\u2013179 (2010).","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"74211_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.gpb.2012.07.005","volume":"10","author":"Y Li","year":"2012","unstructured":"Li, Y. & Kowdley, K. V. MicroRNAs in common human diseases. Genomics Proteomics Bioinform. 10, 246\u2013253 (2012).","journal-title":"Genomics Proteomics Bioinform."},{"key":"74211_CR15","doi-asserted-by":"publisher","first-page":"e000254","DOI":"10.1136\/bmjophth-2018-000254","volume":"4","author":"M Ueta","year":"2019","unstructured":"Ueta, M. et al. Gene expression analysis of conjunctival epithelium of patients with Stevens\u2013Johnson syndrome in the chronic stage. BMJ Open Ophthalmol. 4, e000254 (2019).","journal-title":"BMJ Open Ophthalmol."},{"key":"74211_CR16","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1136\/bjo.2010.180554","volume":"94","author":"M Ueta","year":"2010","unstructured":"Ueta, M., Mizushima, K., Yokoi, N., Naito, Y. & Kinoshita, S. Gene-expression analysis of polyI:C-stimulated primary human conjunctival epithelial cells. Br. J. Ophthalmol. 94, 1528\u20131532 (2010).","journal-title":"Br. J. Ophthalmol."},{"key":"74211_CR17","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.3233\/JAD-190583","volume":"72","author":"S Kumar","year":"2019","unstructured":"Kumar, S. & Reddy, P. H. A new discovery of microRNA-455-3p in Alzheimer\u2019s disease. J. Alzheimers Dis. 72, S117\u2013S130 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"74211_CR18","first-page":"6150","volume":"18","author":"W Wang","year":"2019","unstructured":"Wang, W., Mu, S., Zhao, Q., Xue, L. & Wang, S. Identification of differentially expressed microRNAs and the potential of microRNA-455-3p as a novel prognostic biomarker in glioma. Oncol. Lett. 18, 6150\u20136156 (2019).","journal-title":"Oncol. Lett."},{"key":"74211_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-017-0669-9","volume":"16","author":"A Liu","year":"2017","unstructured":"Liu, A. et al. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma. Mol. Cancer 16, 106 (2017).","journal-title":"Mol. Cancer"},{"key":"74211_CR20","doi-asserted-by":"publisher","first-page":"19455","DOI":"10.18632\/oncotarget.14307","volume":"8","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Oncotarget 8, 19455\u201319466 (2017).","journal-title":"Oncotarget"},{"key":"74211_CR21","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.12659\/MSM.898452","volume":"22","author":"J Zheng","year":"2016","unstructured":"Zheng, J., Lin, Z., Zhang, L. & Chen, H. MicroRNA-455-3p inhibits tumor cell proliferation and induces apoptosis in HCT116 human colon cancer cells. Med. Sci. Monit. 22, 4431\u20134437 (2016).","journal-title":"Med. Sci. Monit."},{"key":"74211_CR22","doi-asserted-by":"publisher","first-page":"15808","DOI":"10.1074\/jbc.RA119.010800","volume":"294","author":"Y Zeng","year":"2019","unstructured":"Zeng, Y. et al. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-beta signaling. J. Biol. Chem. 294, 15808\u201315825 (2019).","journal-title":"J. Biol. Chem."},{"key":"74211_CR23","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.2147\/CMAR.S235794","volume":"12","author":"T Zhan","year":"2020","unstructured":"Zhan, T. et al. miR-455-3p functions as a tumor suppressor by restraining Wnt\/beta-catenin signaling via TAZ in pancreatic cancer. Cancer Manag. Res. 12, 1483\u20131492 (2020).","journal-title":"Cancer Manag. Res."},{"key":"74211_CR24","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3892\/or.2017.5502","volume":"37","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y. et al. MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer. Oncol. Rep. 37, 2449\u20132458 (2017).","journal-title":"Oncol. Rep."},{"key":"74211_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0322-3","volume":"51","author":"S Hu","year":"2019","unstructured":"Hu, S. et al. MicroRNA-455-3p promotes TGF-beta signaling and inhibits osteoarthritis development by directly targeting PAK2. Exp. Mol. Med. 51, 1\u201313 (2019).","journal-title":"Exp. Mol. Med."},{"key":"74211_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13287-020-1550-0","volume":"11","author":"M Shao","year":"2020","unstructured":"Shao, M. et al. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Res. Ther. 11, 37 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"74211_CR27","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ajo.2008.12.040","volume":"147","author":"Y Araki","year":"2009","unstructured":"Araki, Y. et al. Successful treatment of Stevens\u2013Johnson syndrome with steroid pulse therapy at disease onset. Am. J. Ophthalmol. 147, 1004-1011.e1 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"74211_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0041-008X(03)00301-6","volume":"192","author":"JL Lee","year":"2003","unstructured":"Lee, J. L., Mukhtar, H., Bickers, D. R., Kopelovich, L. & Athar, M. Cyclooxygenases in the skin: Pharmacological and toxicological implications. Toxicol. Appl. Pharmacol. 192, 294\u2013306 (2003).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"74211_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaci.2009.04.029","volume":"124","author":"T Honda","year":"2009","unstructured":"Honda, T. et al. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. J. Allergy Clin. Immunol. 124, 809-818.e2 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"74211_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaci.2008.09.044","volume":"123","author":"M Ueta","year":"2009","unstructured":"Ueta, M., Matsuoka, T., Narumiya, S. & Kinoshita, S. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J. Allergy Clin. Immunol. 123, 466\u2013471 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"74211_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms21041275","volume":"21","author":"M Furue","year":"2020","unstructured":"Furue, M., Furue, K., Tsuji, G. & Nakahara, T. Interleukin-17A and keratinocytes in psoriasis. Int. J. Mol. Sci. 21, 1275 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"74211_CR32","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/ijms17081278","volume":"17","author":"P Koczera","year":"2016","unstructured":"Koczera, P., Martin, L., Marx, G. & Schuerholz, T. The ribonuclease A superfamily in humans: Canonical RNases as the buttress of innate immunity. Int. J. Mol. Sci. 17, 1278 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"74211_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.brainresbull.2009.10.001","volume":"81","author":"M Ueta","year":"2010","unstructured":"Ueta, M. & Kinoshita, S. Innate immunity of the ocular surface. Brain Res. Bull. 81, 219\u2013228 (2010).","journal-title":"Brain Res. Bull."},{"key":"74211_CR34","doi-asserted-by":"publisher","first-page":"DES183","DOI":"10.1167\/iovs.17-23537","volume":"59","author":"M Ueta","year":"2018","unstructured":"Ueta, M. Results of detailed investigations into Stevens\u2013Johnson syndrome with severe ocular complications. Investig. Ophthalmol. Vis. Sci. 59, DES183\u2013DES191 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"74211_CR35","doi-asserted-by":"publisher","first-page":"10236","DOI":"10.1074\/jbc.270.17.10236","volume":"270","author":"W Chu","year":"1995","unstructured":"Chu, W., Burns, D. K., Swerlick, R. A. & Presky, D. H. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J. Biol. Chem. 270, 10236\u201310245 (1995).","journal-title":"J. Biol. Chem."},{"key":"74211_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbrc.2015.06.118","volume":"464","author":"XH Liu","year":"2015","unstructured":"Liu, X. H., Bauman, W. A. & Cardozo, C. ANKRD1 modulates inflammatory responses in C2C12 myoblasts through feedback inhibition of NF-kappaB signaling activity. Biochem. Biophys. Res. Commun 464, 208\u2013213 (2015).","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"74211_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10735-012-9459-2","volume":"44","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Increased expression of Gem after rat sciatic nerve injury. J. Mol. Histol. 44, 27\u201336 (2013).","journal-title":"J. Mol. Histol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74211-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74211-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74211-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:00:30Z","timestamp":1670360430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74211-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74211"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74211-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MU declares that the work described in the present paper was supported by grants-in-aid from ROHTO Pharmaceutical Co., Ltd. MU, CS, SK are submitting the patent related with this study with the company. HN, NY, KM, YN declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17239"}}